Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Blend · Innovator

CANC Holdings: What Tema Oncology ETF Owns

Ticker CANC · Since 2023-08-15 · · Holdings as of May 31, 2026

Expense ratio
0.75%$75/yr per $10k
1-yr return
+42.8%as of Dec 2025
Net assets
$176.1Mall share classes
Holdings
57

Bottom line

What does CANC hold?

CANC held 57 positions as of May 31, 2026. Its largest holding is Revolution Medicines Inc at 7.73% of the fund, and the top 10 positions add up to 42.9%. By asset type it is 99% stocks, 1% cash & short-term funds.

Updated Jul 29, 2026

CANC top 25 holdings

#HoldingType% of fundValue
1 Revolution Medicines Inc RVMD Stocks 7.73%$13.6M
2 Eli Lilly & Co LLY Stocks 4.82%$8.5M
3 Roche Holding AG RHHBY Stocks 4.21%$7.4M
4 Cogent Biosciences Inc COGT Stocks 4.10%$7.2M
5 Novartis AG NOVN Stocks 4.03%$7.1M
6 Immunome Inc IMNM Stocks 3.91%$6.9M
7 Celcuity Inc CELC Stocks 3.58%$6.3M
8 Merck & Co Inc MRK Stocks 3.57%$6.3M
9 AstraZeneca PLC AZN Stocks 3.54%$6.2M
10 Nuvalent Inc NUVL Stocks 3.37%$5.9M
11 Bristol-Myers Squibb Co BMY Stocks 3.30%$5.8M
12 Legend Biotech Corp LEGN Stocks 2.99%$5.3M
13 AbbVie Inc ABBV Stocks 2.81%$4.9M
14 Exelixis Inc EXEL Stocks 2.78%$4.9M
15 Bridgebio Pharma Inc BBIO Stocks 2.75%$4.8M
16 Johnson & Johnson JNJ Stocks 2.55%$4.5M
17 CG oncology Inc CGON Stocks 2.43%$4.3M
18 Genmab A/S GMAB Stocks 2.37%$4.2M
19 Ideaya Biosciences Inc IDYA Stocks 2.27%$4.0M
20 Amgen Inc AMGN Stocks 2.11%$3.7M
21 Zai Lab Ltd ZLAB Stocks 1.98%$3.5M
22 BeOne Medicines Ltd ONC Stocks 1.88%$3.3M
23 Zymeworks Inc ZYME Stocks 1.51%$2.7M
24 Enliven Therapeutics Inc ELVN Stocks 1.31%$2.3M
25 Relay Therapeutics Inc RLAY Stocks 1.28%$2.3M

Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026

Asset mix

Stocks99.0%
Cash & short-term funds1.1%

Country exposure

CH8.2%
CN2.0%
DE1.1%
DK2.4%
GB4.0%
HK0.4%
JP0.7%
KY0.3%
US80.9%